Progress in Applied Microbiology

ISSN: 2630-4791 (Online)

Journal Abbreviation: Prog Appl Microbiol

Publication Frequency: quarterly

Article Processing Charges (APC): Click here for more details

Publishing Model: Open Access

Journal no: 49P

About the Journal

Progress in Applied Microbiology is an international Open Access journal that publishes original research articles and review articles related to all areas of applied microbiology. The topics of interest include but not limited to applied microbial, cell physiology, genomics, proteomics, transcriptomics, taxonomy, classification, agricultural, industrial and food microbiology.



News: Scientists Are Retooling Bacteria to Cure Disease


In a study carried out over the summer, a group of volunteers drank a white, peppermint-ish concoction laced with billions of bacteria. The microbes had been engineered to break down a naturally occurring toxin in the blood.

The vast majority of us can do this without any help. But for those who cannot, these microbes may someday become a living medicine.

Posted: 2018-09-11

News: Special antibodies could lead to HIV vaccine


A small number of people who are infected with HIV-1 produce very special antibodies. These antibodies do not just fight one virus strain, but neutralize almost all known virus strains. Research into developing an HIV vaccine focuses on discovering the factors responsible for the production of such antibodies.

HIV-1 genome influences immune reaction

A Swiss research team led by the University of Zurich (UZH) and University Hospital Zurich (USZ) has been searching for these factors for years. Several have already been identified……

Posted: 2018-09-11



Emmanuelle Charpentier of the Max Planck Institute for Infection Biology, an ASM member, and Jennifer Doudna of the University of California, Berkeley, a fellow of the American Academy of Microbiology, were awarded the Kavli Prize in Nanoscience “for the invention of CRISPR-Cas9, a precise nanotool for editing DNA, causing a revolution in biology, agriculture, and medicine.” “CRISPR-Cas9 confers to society enormous capabilities for positive innovations. Possible benefits are wide-ranging in scope and value. CRISPR-Cas9 is a breakthrough nanotool that will considerably enhance our understanding of genetic mechanisms,” said Arne Brataas, chair of the nanoscience prize committee, in a statement.
Posted: 2018-09-11
More Announcements...